Exelixis Inc. [NASDAQ: EXEL] slipped around -0.24 points on Tuesday, while shares priced at $23.45 at the close of the session, down -1.01%. The company report on July 29, 2020 that Exelixis to Release Second Quarter 2020 Financial Results on Thursday, August 6, 2020.
– Conference Call and Webcast to Follow at 5:30 p.m. EDT / 2:30 p.m. PDT –.
Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 after the markets close. At 5:30 p.m. EDT / 2:30 p.m. PDT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company’s website.
Exelixis Inc. stock is now 33.09% up from its year-to-date (YTD) trading value. EXEL Stock saw the intraday high of $23.565 and lowest of $22.90 per share. The company’s 52-week high price is 27.80, which means current price is +71.54% above from all time high which was touched on 05/12/20.
Compared to the average trading volume of 2.66M shares, EXEL reached a trading volume of 1594972 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Exelixis Inc. [EXEL]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXEL shares is $30.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXEL stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for Exelixis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 04, 2020. While these analysts kept the previous recommendation, SunTrust raised their target price to Buy. The new note on the price target was released on January 13, 2020, representing the official price target for Exelixis Inc. stock. Previously, the target price had yet another raise to $22, while BofA/Merrill analysts kept a Buy rating on EXEL stock.
The Average True Range (ATR) for Exelixis Inc. is set at 0.88, with the Price to Sales ratio for EXEL stock in the period of the last 12 months amounting to 7.56. The Price to Book ratio for the last quarter was 4.10, with the Price to Cash per share for the same quarter was set at 3.02. Price to Free Cash Flow for EXEL in the course of the last twelve months was 18.16 with Quick ratio for the last quarter at 8.00.
How has EXEL stock performed recently?
Exelixis Inc. [EXEL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.74. With this latest performance, EXEL shares gained by 1.34% in over the last four-week period, additionally plugging by 33.24% over the last 6 months – not to mention a rise of 18.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EXEL stock in for the last two-week period is set at 46.43, with the RSI for the last a single of trading hit 41.47, and the three-weeks RSI is set at 47.52 for Exelixis Inc. [EXEL]. The present Moving Average for the last 50 days of trading for this stock 23.71, while it was recorded at 23.57 for the last single week of trading, and 20.19 for the last 200 days.
Exelixis Inc. [EXEL]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Exelixis Inc. [EXEL] shares currently have an operating margin of +38.18 and a Gross Margin at +96.58. Exelixis Inc.’s Net Margin is presently recorded at +33.17.
Return on Total Capital for EXEL is now 24.31, given the latest momentum, and Return on Invested Capital for the company is 21.16. Return on Equity for this stock inclined to 21.59, with Return on Assets sitting at 19.35. When it comes to the capital structure of this company, Exelixis Inc. [EXEL] has a Total Debt to Total Equity ratio set at 3.01. Additionally, EXEL Total Debt to Total Capital is recorded at 2.92, with Total Debt to Total Assets ending up at 2.68. Long-Term Debt to Equity for the company is recorded at 2.85, with the Long-Term Debt to Total Capital now at 2.76.
Reflecting on the efficiency of the workforce at the company, Exelixis Inc. [EXEL] managed to generate an average of $520,279 per employee. Receivables Turnover for the company is 6.47 with a Total Asset Turnover recorded at a value of 0.58.Exelixis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.00 and a Current Ratio set at 8.10.
Earnings analysis for Exelixis Inc. [EXEL]
With the latest financial reports released by the company, Exelixis Inc. posted 0.25/share EPS, while the average EPS was predicted by analysts to be reported at 0.23/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 8.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EXEL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Exelixis Inc. go to 46.00%.
Insider trade positions for Exelixis Inc. [EXEL]
There are presently around $5,844 million, or 83.10% of EXEL stock, in the hands of institutional investors. The top three institutional holders of EXEL stocks are: BLACKROCK INC. with ownership of 30,234,952, which is approximately -5.023% of the company’s market cap and around 1.30% of the total institutional ownership; VANGUARD GROUP INC, holding 28,902,587 shares of the stock with an approximate value of $677.77 million in EXEL stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $470.67 million in EXEL stock with ownership of nearly 11.792% of the company’s market capitalization.
Positions in Exelixis Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 194 institutional holders increased their position in Exelixis Inc. [NASDAQ:EXEL] by around 38,258,569 shares. Additionally, 148 investors decreased positions by around 29,807,368 shares, while 55 investors held positions by with 181,158,496 shares. The mentioned changes placed institutional holdings at 249,224,433 shares, according to the latest SEC report filing. EXEL stock had 62 new institutional investments in for a total of 12,483,210 shares, while 41 institutional investors sold positions of 10,787,650 shares during the same period.